Ambroxol

Therapeutic Class	Secretolytic (Mucolytic) and secretomotoric
Indications	Ambroxol is a secretolytic agent used in the treatment of respiratory diseases associated with viscid or excessive mucus. Oral Adult: 60-120 mg daily, in 2-3 divided doses. Child: <2 yr: 7.5 mg bid; 2-5 yr: 7.5 mg bid/tid; 6-12 yr: 15 mg bid/tid.
Adverse Reactions	Mild GI effects and allergic reactions.
Mechanism of Actions	Ambroxol is a metabolite of bromhexine and is very potent inhibitor of the neuronal Na+ channels,with secretolytic and secretomotoric actions that restore the physiological clearance mechanisms of the respiratory tract, which play an important role in the body’s natural defence mechanisms. It stimulates synthesis and release of surfactant by type II pneumocytes. Surfactant acts as an anti-glue factor by reducing the adhesion of mucus to the bronchial wall, in improving its transport and in providing protection against infection and irritating agents
Administration	Should be taken with food.
ATC Classification	R05CB06
GenericPedia Classification	Cough & Cold Preparations, Respiratory system
Available As	Ambroxol 1.5 mg Ambroxol 10 mg Ambroxol 100 mg Ambroxol 120 mg Ambroxol 15 mg Ambroxol 2 mg Ambroxol 20 mg Ambroxol 3 mg Ambroxol 30 mg Ambroxol 45 mg Ambroxol 5 mg Ambroxol 50 mg Ambroxol 60 mg Ambroxol 7.5 mg Ambroxol 75 mg

Subscribe to our e-mail newsletter to receive updates.

Ambroxol Containing Brands

We are Developing Our database, More results coming soon.

Ambroxol is used in following diseases

We are Developing Our database, More results coming soon.

Drug - Drug Interactions of Ambroxol

We are Developing Our database, More results coming soon.